ABVC (STOCKS)
ABVC BioPharma, Inc. Common Stock
$1.260000
+0.070000 (+5.88%)
Prev close: $1.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Uttam Yashwant Patil
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $33.02M
- Employees
- 19
- P/E (TTM)
- -3.06
- P/B (TTM)
- 2.85
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$-0.06 | $0.00 | +0.0000 | +0.00% |
|
Jun 2023 (Q2)
|
$-0.68 | $-0.06 | -0.6188 | -1,011.11% |
|
Mar 2023 (Q1)
|
$-0.60 | $-0.51 | -0.0900 | -17.65% |
|
Dec 2022 (Q4)
|
$-1.50 | $-1.53 | +0.0300 | +1.96% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | -$1.07M |
| Operating Expenses | $8.03M |
| Selling, General, and Administrative Expenses | $3.02M |
| Research and Development | $125.32K |
| Other Operating Expenses | $4.88M |
| Operating Income/Loss | -$8.03M |
| Income/Loss Before Equity Method Investments | -$8.32M |
| Income/Loss From Continuing Operations After Tax | -$9.12M |
| Income/Loss From Continuing Operations Before Tax | -$9.10M |
| Income/Loss From Equity Method Investments | -$783.55K |
| Net Income/Loss | -$9.12M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$495.99K |
| Net Income/Loss Attributable To Parent | -$8.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$10.41M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.39 |
| Diluted Earnings Per Share | -$0.39 |
| Basic Average Shares | 30,589,228 |
| Diluted Average Shares | 30,589,228 |
| Assets | $19.73M |
| Current Assets | $648.85K |
| Noncurrent Assets | $19.08M |
| Fixed Assets | $12.82M |
| Non-current Prepaid Expenses | $1.79M |
| Other Non-current Assets | $4.47M |
| Liabilities | $6.90M |
| Current Liabilities | $5.39M |
| Wages | $31.39K |
| Other Current Liabilities | $5.36M |
| Noncurrent Liabilities | $1.51M |
| Equity | $12.83M |
| Equity Attributable To Noncontrolling Interest | $2.06M |
| Equity Attributable To Parent | $10.77M |
| Liabilities And Equity | $19.73M |
| Net Cash Flow From Operating Activities | -$3.34M |
| Net Cash Flow From Operating Activities, Continuing | -$3.34M |
| Net Cash Flow From Investing Activities | -$1.27M |
| Net Cash Flow From Investing Activities, Continuing | -$1.27M |
| Net Cash Flow From Financing Activities | $3.87M |
| Net Cash Flow From Financing Activities, Continuing | $3.87M |
| Exchange Gains/Losses | $16.07K |
| Net Cash Flow | -$716.66K |
| Net Cash Flow, Continuing | -$732.74K |
| Comprehensive Income/Loss | -$8.57M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.57M |
| Other Comprehensive Income/Loss | $551.46K |